subscribe to our newsletter sign up
Corrs’ coffers healthy after acting on major merger

Corrs’ coffers healthy after acting on major merger

Corrs Chambers Westgarth and Chapman Tripp have acted on one of the largest health sector transactions in recent years.

Firms: Corrs Chambers Westgarth (Zuellig – the owners of Symbion); Chapman Tripp (EBOS Group)

Deal: Australian pharmaceutical wholesaler Symbion has merged with New Zealand’s EBOS Group

Area: M&A

Value: $NZ1.5 billion

Key players: For Corrs, the deal was lead by corporate and M&A partner Justin Fox (pictured). Alister McDonald led the transaction for Chapman Tripp

Deal significance: This is one of the largest health sector transactions in recent years. The merger has created Australasia’s largest wholesaler and distributor of healthcare products and will see EBOS become the third largest New Zealand listed company by revenue. Corrs’ lead partner Justin Fox said: “Corrs is proud to have been involved in this deal, which is important to every Australian household.”

Promoted content
Recommended by Spike Native Network
X